Results 161 to 170 of about 114,817 (184)

The cannabinoid receptor 1 suppresses neuropeptide Y transcription in the peripheral nervous system to mediate analgesia. [PDF]

J Biol Chem
Liu Y, Gong X, Wang Y, Huang Z, Li J, Wan K, Liu W, Kou L, Bi F, Li M.   +9 more
europepmc   +1 more source

Neuropeptides in the Management of Alzheimer's Disease: From Pathophysiology to Therapeutic Opportunities. [PDF]

Int J Mol Sci
Tiwari S, Yadav SK, Kumari M, Dhakal T, Puranik N.   +4 more
europepmc   +1 more source

Mass Spectrometry-Based Peptidomics for the Discovery and Profiling of Endogenous Peptides in Crustacean Hemolymph. [PDF]

ACS Omega
Dang TC, Tran VNH, Protya SS, Beaver M, Yi KW, Li L.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neuropeptide Y effector systems: perspectives for drug development

Trends in Pharmacological Sciences, 1994
Rolf Håkanson, Lars Grundemar
exaly  

Neuropeptide Y has a stimulatory action on feeding behavior in goldfish ()

European Journal of Pharmacology, 1999
Marcos A. López-Patiño, María Jesús Delgado, Nuria De Pedro   +2 more
exaly  

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y receptor antagonists and neuropeptide Y Y receptor agonists

European Journal of Pharmacology, 1998
Ambikaipakan Balasubramaniam, Robert E Burrier, Eric M Parker   +2 more
exaly  

The first highly potent and selective non-peptide neuropeptide Y Y receptor antagonist: BIBP3226

European Journal of Pharmacology, 1994
Annette Gabriele Beck-Sickinger, Heike A Wieland, Henri N Doods   +2 more
exaly  

Effect of a selective neuropeptide Y Y receptor antagonist, BIIE0246 on neuropeptide Y release

European Journal of Pharmacology, 2000
Peter S Widdowson, P S Widdowson
exaly  

Amygdalar neuropeptide Y Y receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test

European Journal of Pharmacology, 1999
Donald R Gehlert, Tammy J Sajdyk
exaly